LB Pharmaceuticals
The Director of Statistical Programming at LB Pharmaceuticals will lead the creation and growth of the internal statistical programming function, building team, infrastructure, and processes to support late-stage clinical trials and BLA submissions. This hands‑on technical leader will collaborate with biometrics, biostatistics, clinical operations, and regulatory affairs to deliver high‑quality programming deliverables and oversee vendor activities.
LB Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel therapies for the treatment of neuropsychiatric diseases, including schizophrenia and bipolar depression. The company's lead product candidate, LB-102, is an oral small molecule with the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States. LB Pharmaceuticals is building a pipeline that leverages the broad therapeutic potential of LB-102 across multiple neuropsychiatric indications.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for LB Pharmaceuticals.
3% above the average for this role
Principal Statistical Programmer
Cytel
Principal Statistical Programmer
Cytel
Principal Statistical Programmer
Cytel
Associate Principal Scientist, Statistical Programmer | Oncology (Hybrid)
MSD
Sr. Scientist, Statistical Programmer, Late Stage Development Oncology- Hybrid
MSD
Senior Manager, Statistical Programming
Beam Therapeutics